Symptomatic Ascites Drainage With a Patient-controlled Vascular Catheter.
Management of Symptomatic Malignant Ascites With an Patient-controlled, Vascular Catheter - a Validation Study.
1 other identifier
observational
170
2 countries
2
Brief Summary
The purpose of this study is to determine whether drainage with the usage of a fine, patient-controlled vascular catheter inserted into abdominal cavity is a feasible, safe and effective method in the management of symptomatic malignant ascites. Complications' rate of the procedure and patients' quality of life, nutritional status and experience on the treatment are main endpoints.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2016
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 20, 2016
CompletedFirst Posted
Study publicly available on registry
March 31, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedFebruary 23, 2023
February 1, 2023
7.6 years
March 20, 2016
February 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of participants with adverse events.
Early and late adverse events of the catheter placement and later drainage to be recorded.
2 weeks
Change in quality of life.
Change in quality of life measured with standard questionnaire EORTC-C15-PAL before the procedure and 1-2 weeks later.
2 weeks
Secondary Outcomes (4)
Number of participants with drainage complication during cancer treatment vs observation.
1 month
Number of participants with successful catheter placement.
2 weeks
Patient's experience on the treatment.
2 weeks
Change in nutrition habits.
2 weeks
Other Outcomes (2)
Change in nutrition status among participants with prolonged ascites drainage.
1 month
Number of ambulatory visits or hospital admissions.
1 month
Study Arms (1)
Symptomatic ascites drainage with CVC.
Patients with malignant, symptomatic, refractory ascites. Ascites drainage with vascular catheter (CVC) inserted into abdominal cavity will be performed. Patients will be asked to complete interview, quality of life questionnaire, nutritional status assessment and quality of procedure survey.
Interventions
In case of symptomatic malignant ascites, the procedure of vascular catheter insertion into abdominal cavity will be performed, followed by slow, systematic drainage, on patient's demand.
Interview with patients will be performed according to attached chart. The aim is to collect data concerning patient's symptoms, co-morbidity, and basic clinical data about the primary malignancy and treatment status.
Quality of life questionnaire (QLQ). Patients will be asked to complete QLQ at two time points: 1. immediately before the procedure, 2. one or two weeks after the procedure.
Patients will be asked to complete quality of procedure questionnaire at one time point: one or two weeks after the procedure.
Risk of malnutrition and ability to feed normally will be assessed with specific questionnaire at two time points: 1. immediately before the procedure, 2. one or two weeks after the procedure.
Eligibility Criteria
Patients considered eligible are those with malignant disease of any origin and coexisting symptomatic ascites who require a management anyway.
You may qualify if:
- patients with symptomatic, refractory malignant ascites,
- supportive care (professional or family members) available at patients' home,
- informed signed consent of the patient.
You may not qualify if:
- ascites not of malignant origin,
- asymptomatic ascites,
- suspected or clinically apparent infection especially at the site of planned drainage placement,
- significant coagulopathy,
- very poor performance status (PS4),
- patient not able to read and sign informed consent,
- mucinous ascites.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
The Central and Eastern European Gynecologic Oncology Group (CEEGOG)
Prague, Czechia
Gdynia Oncology Center
Gdynia, 81-519, Poland
Related Publications (6)
Hui D, Bruera E. Integrating palliative care into the trajectory of cancer care. Nat Rev Clin Oncol. 2016 Mar;13(3):159-71. doi: 10.1038/nrclinonc.2015.201. Epub 2015 Nov 24.
PMID: 26598947BACKGROUNDStephenson J, Gilbert J. The development of clinical guidelines on paracentesis for ascites related to malignancy. Palliat Med. 2002 May;16(3):213-8. doi: 10.1191/0269216302pm509oa.
PMID: 12046997RESULTBecker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment. Eur J Cancer. 2006 Mar;42(5):589-97. doi: 10.1016/j.ejca.2005.11.018. Epub 2006 Jan 24.
PMID: 16434188RESULTStukan M, Lesniewski-Kmak K, Wroblewska M, Dudziak M. Management of symptomatic ascites and post-operative lymphocysts with an easy-to-use, patient-controlled, vascular catheter. Gynecol Oncol. 2015 Mar;136(3):466-71. doi: 10.1016/j.ygyno.2014.11.073. Epub 2014 Nov 28.
PMID: 25434633RESULTda Silva Fink J, Daniel de Mello P, Daniel de Mello E. Subjective global assessment of nutritional status - A systematic review of the literature. Clin Nutr. 2015 Oct;34(5):785-92. doi: 10.1016/j.clnu.2014.12.014. Epub 2014 Dec 26.
PMID: 25596153RESULTStukan M. Drainage of malignant ascites: patient selection and perspectives. Cancer Manag Res. 2017 Apr 12;9:115-130. doi: 10.2147/CMAR.S100210. eCollection 2017.
PMID: 28442933RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maciej Stukan, MD
Gdynia Oncology Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Weeks
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
March 20, 2016
First Posted
March 31, 2016
Study Start
January 1, 2016
Primary Completion
August 1, 2023
Study Completion
December 1, 2023
Last Updated
February 23, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share